Abstract
The management of high-risk and relapsed/refractory (R/R) MM patients remain a therapeutic challenge as outcomes remain poor. The most part of these patients ultimately become refractory to treatment, due in part to a lack of a successful mechanism-based therapies and genetic instability with numeric chromosomal abnormalities. Aurora kinase B (AURKB) is a key regulator of mitosis as a component of the chromosomal passenger complex (CPC). The CPC has essential functions at the centromere in ensuring correct chromosome alignment and segregation and is required for chromatin-induced microtubule stabilization and spindle assembly as well as orderly cytokinesis.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
